Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications


You May Also Like

Data on Delcath’s CHEMOSAT System Presented at CIRSE Annual Meeting

NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...

Risk of Work Time Loss Almost Double for Osteoarthritis Sufferers

TORONTO, March 24, 2016 (GLOBE NEWSWIRE) -- Osteoarthritis (OA) sufferers have almost twice the ...